Drugs / PF-05230901
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01262690 | Nov 2010 → Sep 2011 | hypoproteinemia, hypercatabolic | Pfizer | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-05230901 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01262690 ↗ |
| Route | Subcutaneous | “PF-05230901 Administered Subcutaneously” NCT01262690 ↗ |